Health Care & Life Sciences » Biotechnology | Cancer Genetics Inc.

Cancer Genetics Inc.

Cancer Genetics Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$9.83 M
Shares Outstanding
57.82 M
Public Float
33.73 M


Meadows Office Complex
Rutherford New Jersey 07070
United States
Employees -
Updated 07/08/2019
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S.


View All

John Pappajohn
Non-Executive Chairman
Raju S. K. Chaganti